Bioshore Capital Partners
Overview
Bioshore Capital Partners is a venture capital firm based in Sydney, Australia that invests in early-stage medical and biotech opportunities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leo Cancer Care | Jul 2026 | Series D | Co-investor |
| Kitea Health | Dec 2025 | Early Funding | Co-investor |
| Wellumio | Jul 2026 | Early Funding | Co-investor |
| Vexev | Aug 2026 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bioshore Capital Partners based?
Bioshore Capital Partners is headquartered in Sydney, Australia.
When was Bioshore Capital Partners founded?
Bioshore Capital Partners was founded in 2019.
How many portfolio companies does Bioshore Capital Partners have?
Bioshore Capital Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in Bioshore Capital Partners's portfolio?
Portfolio companies visible on Caplight include Leo Cancer Care, Kitea Health, Wellumio, Vexev.
What was Bioshore Capital Partners's most recent investment shown here?
Bioshore Capital Partners's most recent investment in this portfolio sample was in Vexev in 2026.
What sectors does Bioshore Capital Partners focus on?
Bioshore Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Bioshore Capital Partners focus on?
Stage focus information for Bioshore Capital Partners is not publicly available.